You are using an older browser version. Please use a supported version for the best MSN experience.

Drug will 'change landscape of Alzheimer's treatment'

The results of a key Alzheimer's drug trial on Wednesday (Sept 28) have reignited decades-old hopes that targeting a particular protein helps arrest the progression of the fatal brain disease, giving a big boost to similar studies being run by Roche and Eli Lilly. WATCH MORE: SUBSCRIBE: LIKE:

Most Recent

image beaconimage beaconimage beacon